Background evidence summaries (major themes):
• Dermatologic/pre-malignant skin lesions: multiple systematic reviews and RCTs report PDT efficacy for Bowen disease (pooled clearance ~76%) and more limited/heterogeneous results for cutaneous SCC (pooled clearance ~51%) and nodular BCC (higher recurrence vs excision but better cosmetic outcomes).
• Wound healing and antimicrobial effects: systematic reviews of human and animal studies suggest PDT can reduce bacterial counts, stimulate fibroblasts and collagen, and accelerate healing, but data are heterogeneous and largely from small or preclinical studies.
• Endodontic/periodontal infections and peri-implant disease: multiple meta-analyses and systematic reviews report mixed or limited benefit of adjunctive antimicrobial PDT (aPDT) with some short-term microbial load reductions and small clinical gains; high heterogeneity and limited high-quality RCTs.
• Cervical intraepithelial neoplasia/HPV: meta-analysis of RCTs showed increased complete response and HPV clearance with PDT (ORs reported) but overall evidence quality rated very low and higher adverse event rates were observed.
• Oral leukoplakia and other oral premalignant lesions: systematic reviews indicate PDT may be useful as a non-surgical option with variable complete/partial response rates and need for standardized PDT parameters and more RCTs.
• Ophthalmologic indications (e.g., chronic central serous chorioretinopathy, wet AMD combinations): trials/meta-analyses show short-term benefits (e.g., reduced subretinal fluid, fewer injections when combined therapy used) but mixed effects on vision outcomes and limited long-term data.
• Actinic cheilitis and other cutaneous precancerous conditions: case series and systematic reviews report clinical responses with variable histologic cure; daylight-PDT may be better tolerated; evidence limited and heterogeneous.
• Other indications (lichen sclerosus, herpes labialis, dyspigmentation/photoaging/scarring, chronic rhinosinusitis, SARS-CoV-2 inactivation, peritoneal carcinomatosis, mesothelioma, brain tumors, extra-mammary Paget's disease, peri-implantitis): substantial literature exists but consists largely of small studies, case series, or preclinical data; many uses remain investigational with predominantly low-quality, heterogeneous evidence and a need for larger, well-designed RCTs.